Table 3.
Neutralizing antibody responses of individual ewes in the Phase II Group #3 study. These animals received 1 × 104 PFU s.c. of the arMP-12ΔNSm 21/384 vaccine candidate. At necropsy, ewes #56 and #57 were not pregnant and ewe #48 had a dead, partially autolyzed fetus from which PCR products consistent with the input virus were recovered. All other ewes had live, morphologically normal fetuses.
| Phase II Group #3 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| arMP-12ΔNSm 21/384 (1 × 104 PFU) | ||||||||||
| Day | #45† | #46 | #47 | #48 | #53 | #54 | #55 | #56 | #57 | #58 |
| 1 | <1:10‡ | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 |
| 2 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 |
| 3 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | 20 | <1:10 | <1:10 | <1:10 | <1:10 |
| 4 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 |
| 5 | <1:10 | <1:10 | 20 | 20 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 |
| 6 | <1:10 | <1:10 | <1:10 | 20 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 | <1:10 |
| 7 | 20 | 20 | 20 | 80 | <1:10 | 20 | 20 | 20 | <1:10 | 20 |
| 9 | 320 | 320 | 1280 | 1280 | <1:10 | 160 | 80 | 320 | 20 | 80 |
| 13 | 640 | 2560 | 5120 | 5120 | 20 | 640 | 320 | 320 | 40 | 160 |
| 20 | 320 | 1280 | 1280 | 5120 | 80 | 320 | 1280 | 1280 | 80 | 320 |
| 27 | 320 | 640 | 1280 | 1280 | 80 | 320 | 1280 | 320 | 80 | 320 |
| 34 | 320 | 2560 | 1280 | 1280 | 20 | 320 | 1280 | 320 | 80 | 320 |
| 41 | 320 | 1280 | 320 | 320 | 80 | 320 | 1280 | 320 | 320 | 320 |
| 48 | 80 | 1280 | 320 | 320 | 80 | 160 | 1280 | 320 | 80 | 320 |
| 55 | 320 | 320 | 320 | 320 | 80 | 320 | 1280 | 320 | 80 | 320 |
| 62 | 320 | 1280 | 320 | 1280 | 80 | 320 | 1280 | 320 | 80 | 320 |
Ewe identification number
Data are expressed as the reciprocal of plaque-reduction neutralization 80% antibody titer. Minimum detection limit of the assay is 1:10.